Quidel | QDEL - 销售收入



金融业
股票价格
USD
资产
USD 5.72B
现金及等价物
USD 123.4M
销售成本
USD 407M
流动资产
USD 1.38B
流动负债
USD 993.4M
债务
USD 2.87B
EBIT
USD -15.3M
EBITDA
USD 129.3M
员工
6.6K
EPS每股收益
USD -1.27
股本和储备
USD 1.85B
销售毛利
USD 223.9M
债务利息支出
USD 5.63B
利息收入
USD -1.35
贷款资金
USD 2.54B
市值
USD 931.2M
净收入
USD -92.9M
营业费用
USD 646.2M
营业利润
USD -15.3M
普通股股本
USD 68.1M
PE价格收益
2.03
税前利润
USD -79.5M
销售收入
USD 630.9M
销售和管理费用
USD 189.7M
股票
USD 618.9M
贸易债权人
USD 236.5M
应收帐款人
USD 352M


销售 更改 日
Abbott USD 12.59B 1.43B 2026-06
Agilent USD 1.88B 43M 2026-06
Becton, Dickinson and Co. USD 5B 300M 2026-06
Bruker USD 838.5M 15.1M 2026-06
Cerus USD 50.81M 4.79M 2024-12
Charles River Laboratories USD 1000M 4.2M 2026-06
Danaher USD 6.3B 350M 2026-06
Haemonetics USD 339M 7M 2026-06
Illumina USD 1.16B 70M 2026-06
IQVIA Holdings USD 4.37B 220M 2026-06
Merit Medical Systems USD 418.8M 36.9M 2026-06
Mettler Toledo International USD 1.03B 82.87M 2026-06
Myriad Genetics USD 190.7M 9.7M 2026-06
Neogen USD 225.3M 14.1M 2026-03
OraSure Technologies USD 26.76M 322K 2025-12
Pacific Biosciences Of California USD 44.64M 6.2M 2025-12
Quidel USD 630.9M 10.9M 2026-06
Revvity USD 729.68M 18.68M 2026-06
STAAR Surgical USD 93.5M 0 2026-06
Thermo Fisher Scientific USD 11.99B 980M 2026-06
Waters USD 1.64B 370M 2026-06